USE OF A GENETICALLY MODIFIED CELL LINE EXPRESSING FUNCTIONAL ASIALOGLYCOPROTEIN RECEPTOR IN THE PRODUCTION OF SIALYLATED GLYCOPROTEINS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130059335A1
SERIAL NO

13696335

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to the use of a cell line in the production of sialylated glycoprotein, wherein said cell line expresses functional ASGPR protein as well as to a method for the production of sialylated glycoproteins, characterized in that such a cell line is used.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHARITE - UNIVERSITATSMEDIZIN BERLINCHARITÉPLATZ1 BERLIN 10117

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berger, Markus Berlin, DE 97 402
Kaup, Matthias Berlin, DE 5 2
Lusch, Astrid Berlin, DE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation